Skip to contents

  1. Griesinger, Frank [Author]; Curigliano, G. [Author]; Thomas, Michael [Author]; Subbiah, V. [Author]; Baik, C. S. [Author]; Tan, D. S. W. [Author]; Lee, D. H. [Author]; Misch, D. [Author]; Garralda, E. [Author]; Kim, D. -W [Author]; van der Wekken, A. J. [Author]; Gainor, J. F. [Author]; Paz-Ares, L. [Author]; Liu, S. V. [Author]; Kalemkerian, G. P. [Author]; Houvras, Y. [Author]; Bowles, D. W. [Author]; Mansfield, A. S. [Author]; Lin, J. J. [Author]; Smoljanovic, V. [Author]; Rahman, A. [Author]; Kong, S. [Author]; Zalutskaya, A. [Author]; Louie-Gao, M. [Author]; [...]

    Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy : update from the ARROW trial

    Articles
    View online
    Schließen
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    13 August 2022

    Published in: Annals of oncology ; 33(2022), 11 vom: Nov., Seite 1168-1178

  4. Crane, G; Khan, N; Pedrós, M; Hipp, J; Gally, S; Smoljanovic, V; Gondos, A; Hammerschmidt, S

    Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analysis

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2017

    Published in: Value in Health

  5. Krebs, M.G.; Lin, J.J.; Pal, N.; Polito, L.; Trinh, H.T.L.; Hilton, M.M.S.M.; Smoljanovic, V.; Kurtsikidze, N.; Archer, V.; Zhang, Q.

    1201P Real-world comparative effectiveness of 1L alectinib (ALC) vs crizotinib (CRZ) in patients (pts) with ALK+ advanced NSCLC with or without baseline CNS metastases (mets)

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2021

    Published in: Annals of Oncology

  7. Gadgeel S; Shaw AT; Barlesi F; Crino L; Yang JCH; Dingemans AM; Kim DW; de Marinis F; Schulz M; Liu S; Gupta R; Smoljanovic V; Ou SHI

    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    2019

    Published in: Lung Cancer: Targets and Therapy

  8. Beslija, S.; Banjin, M.; Jungic, S.; Obralic, N.; Kecman-Malcic, G.; Rakita, I.; Salkic, B.; Pasic, A.; Tinjic, L.; Smoljanovic, V.

    Updated phase II study results of capecitabine (X) + irinotecan (I) + bevacizumab (A) as first-line therapy for metastatic colorectal cancer (MCRC)

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2009

    Published in: Journal of Clinical Oncology

  9. Wolf, J.; Helland, Å.; Oh, I.-J.; Migliorino, M.R.; Dziadziuszko, R.; Wrona, A.; de Castro, J.; Mazieres, J.; Griesinger, F.; Chlistalla, M.; Cardona, A.; Ruf, T.; Trunzer, K.; Smoljanovic, V.; Novello, S.

    Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2022

    Published in: ESMO Open

  10. Mok, T.; Camidge, D.R.; Gadgeel, S.M.; Rosell, R.; Dziadziuszko, R.; Kim, D.-W.; Pérol, M.; Ou, S.-H.I.; Ahn, J.S.; Shaw, A.T.; Bordogna, W.; Smoljanović, V.; Hilton, M.; Ruf, T.; Noé, J.; Peters, S.

    Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2020

    Published in: Annals of Oncology

  11. Mok, T.S.K.; Shaw, A.T.; Camidge, R.D.; Gadgeel, S.M.; Rosell, R.; Dziadziuszko, R.; Kim, D.-W.; Perol, M.; Ou, S.-H.; Bordogna, W.; Smoljanović, V.; Hilton, M.; Peters, S.

    Final PFS, updated OS and safety data from the randomised, phase III ALEX study of alectinib (ALC) versus crizotinib (CRZ) in untreated advanced ALK+ NSCLC

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2019

    Published in: Annals of Oncology

  12. Wolf, J.; Helland, Å.; Oh, I.; Migliorino, M.R.; Dziadziuszko, R.; De Castro Carpeno, J.; Mazieres, J.; Griesinger, F.; Chlistalla, M.; Cardona, A.; Ruf, T.; Trunzer, K.; Smoljanovic, V.; Novello, S.

    OA02.07 Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2019

    Published in: Journal of Thoracic Oncology

  13. Griesinger, F; Bennouna, J; de Castro Carpeno, J; Dingemans, AM; Grossi, F; Langer, C; Ohe, Y; Syrigos, K; Thatcher, N; Das-Gupta, A; Donica, M; Smoljanovic, V; Gridelli, C

    Efficacy and safety results from AvaALL: an open-label, randomized phase III trial of standard of care (SOC) with or without continuous bevacizumab (Bev) treatment beyond progression (PD) in patients (pts) with advanced non-small-cell lung cancer (NSCLC) progressing after first-line Bev and chemotherapy (chemo)

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Georg Thieme Verlag KG, 2018

    Published in: Pneumologie

  14. de Castro, J.; Novello, S.; Mazieres, J.; Oh, I.-J.; Migliorino, M.R.; Helland, A.; Dziadziuszko, R.; Griesinger, F.; de Marinis, F.; Zeaiter, A.; Cardona, A.; Balas, B.; Johannsdottir, H.; Chlistalla, M.; Smoljanovic, V.; Wolf, J.

    CNS efficacy results from the phase III ALUR study of alectinib vs chemotherapy in previously treated ALK+ NSCLC

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2017

    Published in: Annals of Oncology

  15. Mazieres, J.; Novello, S.; De Castro, J.; Migliorino, M.R.; Helland, Å.; Dziadziuszko, R.; Griesinger, F.; Wolf, J.; Zeaiter, A.; Cardona, A.; Balas, B.; Karagiannis, T.; Chlistalla, M.; Smoljanovic, V.; Oh, I.

    P1.01-013 Patient-Reported Outcomes and Safety from the Phase III ALUR Study of Alectinib vs Chemotherapy in Pre-Treated ALK+ NSCLC

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2017

    Published in: Journal of Thoracic Oncology

  16. Griesinger, F.; Curigliano, G.; Thomas, M.; Subbiah, V.; Baik, C.S.; Tan, D.S.W.; Lee, D.H.; Misch, D.; Garralda, E.; Kim, D.-W.; van der Wekken, A.J.; Gainor, J.F.; Paz-Ares, L.; Liu, S.V.; Kalemkerian, G.P.; Houvras, Y.; Bowles, D.W.; Mansfield, A.S.; Lin, J.J.; Smoljanovic, V.; Rahman, A.; Kong, S.; Zalutskaya, A.; Louie-Gao, M.; [...]

    Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2022

    Published in: Annals of Oncology